Gerard Champaloux
Family Medicine · Bowie, MDNPI 1205938305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,087 and has fallen 98.7% since, to $28 in 2022.
Across 140 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$440
- Abbott$405
- Novo Nordisk$245
- Lilly USA, LLC$207
- Pfizer$156
- Novartis$134
- plus $885 from 17 others
What the payments were for
- Food & beverage$2,38396%
- Education$894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $440 |
| Abbott | 3 | $405 |
| Novo Nordisk | 23 | $245 |
| Lilly USA, LLC | 15 | $207 |
| Pfizer | 12 | $156 |
| Novartis | 7 | $134 |
| Amgen(2 entities) | 8 | $121 |
| Sanofi-aventis U.S. LLC | 8 | $118 |
| GSK | 5 | $104 |
| Amarin Pharma, Inc. | 4 | $70 |
| AbbVie | 5 | $65 |
| Astellas Pharma US Inc | 4 | $65 |
| Ascensia Diabetes Care US Inc. | 1 | $60 |
| Merck | 4 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Boehringer Ingelheim | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $29 |
| Nevro Corp. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Johnson & Johnson | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Confirm Rx$405
How this compares
$2,471 in reported general payments places this provider in the 80th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desmopressin Acetate | 12 | $3,000 |
| Mesalamine ErMesalamine | 11 | $2,152 |
| Celecoxib | 12 | $921 |
| Gabapentin | 16 | $780 |
| Ketoconazole | 20 | $753 |
| Baclofen | 16 | $683 |
| Levetiracetam | 12 | $596 |
| Tamsulosin Hcl | 19 | $409 |
| Omeprazole | 32 | $383 |
| Fluticasone Propionate | 15 | $319 |
| Potassium Chloride | 19 | $310 |
| Oxybutynin Chloride | 12 | $299 |
| Montelukast Sodium | 19 | $284 |
| Famotidine | 21 | $276 |
| Alendronate Sodium | 26 | $268 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bowie
- Tramaine DavisBowie$43K
- Anna McCallBowie$24K
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.